Description AMMS® organoid-specific matrix gel is made from basement membrane components extracted from mouse tumor tissues, and its main components include laminin, type IV collagen, heparin sulfate proteoglycans, etc. These...

Description Color interference, undefined growth factor activity, and inconsistent gel formation can complicate organoid and three-dimensional cell culture workflows. These variables may make it more difficult to distinguish experimental responses...

Description Establishing patient-derived cholangiocarcinoma organoids from primary tumor tissue can be technically demanding. Variable tissue quality, incomplete tissue digestion, inconsistent culture conditions, and limited post-isolation expansion may reduce organoid establishment...

Description Establishing a reproducible patient-derived colon cancer organoid culture can be difficult when freshly isolated tumor tissue contains variable cell populations, residual blood cells, incompletely digested tissue, or samples with...

Description Establishing reliable patient-derived gastric cancer models can be challenging when researchers need to maintain the biological characteristics of primary tumor samples while achieving consistent expansion in vitro. Traditional two-dimensional...

  Description Establishing reliable human lung cancer organoid models from primary tumor tissues can be challenging due to variations in tumor samples, limited expansion capacity, and the difficulty of maintaining...

Description Establishing reliable human skin organoid models from primary tissue sources can be challenging due to variations in cell quality, differentiation status, and the complexity of maintaining a suitable three-dimensional...

Description Reliable intestinal organoid establishment begins with the recovery of intact, viable intestinal crypts. During conventional intestinal tissue digestion, insufficient dissociation can leave crypts trapped within the mucosa, while excessive...